Works by Regev-Yochay, Gili


Results: 72
    1

    Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 9, p. e2122255, doi. 10.1001/jamanetworkopen.2021.22255
    By:
    • Shavit, Ronen;
    • Maoz-Segal, Ramit;
    • Iancovici-Kidon, Mona;
    • Offengenden, Irena;
    • Haj Yahia, Soad;
    • Machnes Maayan, Diti;
    • Lifshitz-Tunitsky, Yulia;
    • Niznik, Stanley;
    • Frizinsky, Shirly;
    • Deutch, Michal;
    • Elbaz, Eti;
    • Genaim, Hosney;
    • Rahav, Galia;
    • Levy, Itzchak;
    • Belkin, Anna;
    • Regev-Yochay, Gili;
    • Afek, Arnon;
    • Agmon-Levin, Nancy
    Publication type:
    Article
    2
    3
    4
    5
    6

    High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 12, p. 2769, doi. 10.3390/v14122769
    By:
    • Davidov, Yana;
    • Indenbaum, Victoria;
    • Atari, Nofar;
    • Kliker, Limor;
    • Tsaraf, Keren;
    • Asraf, Keren;
    • Cohen-Ezra, Oranit;
    • Likhter, Mariya;
    • Mor, Orna;
    • Doolman, Ram;
    • Weiss-Ottolenghi, Yael;
    • Hod, Tammy;
    • Afek, Arnon;
    • Kreiss, Yitshak;
    • Lustig, Yaniv;
    • Regev-Yochay, Gili;
    • Mandelboim, Michal;
    • Ben-Ari, Ziv
    Publication type:
    Article
    7
    8

    COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022.

    Published in:
    Eurosurveillance (15607917), 2022, v. 27, n. 30, p. 9, doi. 10.2807/1560-7917.es.2022.27.30.2200559
    By:
    • Kliker, Limor;
    • Zuckerman, Neta;
    • Atari, Nofar;
    • Barda, Noam;
    • Gilboa, Mayan;
    • Nemet, Ital;
    • Elkader, Bayan Abd;
    • Fratty, Ilana S;
    • Jaber, Hanaa;
    • Mendelson, Ella;
    • Alroy-Preis, Sharon;
    • Kreiss, Yitshak;
    • Regev-Yochay, Gili;
    • Mandelboim, Michal
    Publication type:
    Article
    9
    10

    The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021.

    Published in:
    Eurosurveillance (15607917), 2021, v. 26, n. 45, p. 4, doi. 10.2807/1560-7917.es.2021.26.45.2100974
    By:
    • Zuckerman, Neta;
    • Nemet, Ital;
    • Kliker, Limor;
    • Atari, Nofar;
    • Lustig, Yaniv;
    • Bucris, Efrat;
    • Ilan, Dana Bar;
    • Geva, Miranda;
    • Sorek-Abramovich, Reut;
    • Weiner, Chen;
    • Rainy, Nir;
    • Bar-Chaim, Adina;
    • Benveniste-Levkovitz, Patricia;
    • Hamed, Ramzia Abu;
    • Regev-Yochay, Gili;
    • Hevkin, Ofra;
    • Mor, Orna;
    • Alroy-Preis, Sharon;
    • Mendelson, Ella;
    • Mandelboim, Michal
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    Methicillin-resistant Staphylococcus aureus in Neonatal Intensive Care Unit.

    Published in:
    Emerging Infectious Diseases, 2005, v. 11, n. 3, p. 453, doi. 10.3201/eid1103.040470
    By:
    • Regev-Yochay, Gili;
    • Rubinstein, Ethan;
    • Barzilai, Asher;
    • Carmeli, Yehuda;
    • Kuint, Jacob;
    • Etienne, Jerome;
    • Blech, Mira;
    • Smollen, Gill;
    • Maayan-Metzger, Ayala;
    • Leavitt, Azita;
    • Rahav, Galia;
    • Keller, Nathan
    Publication type:
    Article
    18
    19
    20
    21

    Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance.

    Published in:
    Clinical Infectious Diseases, 2022, v. 74, n. 9, p. 1639, doi. 10.1093/cid/ciab645
    By:
    • Ben-Shimol, Shalom;
    • Regev-Yochay, Gili;
    • Givon-Lavi, Noga;
    • Beek, Bart Adriaan van der;
    • Brosh-Nissimov, Tal;
    • Peretz, Avi;
    • Megged, Orli;
    • Dagan, Ron;
    • (IPBMG), Israeli Pediatric Bacteremia and Meningitis Group;
    • Group, Israeli Adult Invasive Pneumococcal Disease (IAIPD)
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Healthcare-associated infection prevention and control practices in Israel: results of a national survey.

    Published in:
    BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07721-8
    By:
    • Najjar-Debbiny, Ronza;
    • Chazan, Bibiana;
    • Lobl, Rona;
    • Greene, M. Todd;
    • Ratz, David;
    • Saint, Sanjay;
    • Carmeli, Yehuda;
    • Schwaber, Mitchell J.;
    • the Israel IPC Working Group;
    • Ben-David, Debby;
    • Shitrit, Pnina;
    • Paz, Alona;
    • Brosh-Nissimov, Tal;
    • Mor, Meirav;
    • Regev-Yochay, Gili;
    • Ciobotaro, Pnina;
    • Yinnon, Amos M.;
    • Mar-Chaim, Dror;
    • Rubinovitch, Bina;
    • Hussein, Khetam
    Publication type:
    Article
    46
    47

    Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022.

    Published in:
    Eurosurveillance (15607917), 2022, v. 27, n. 39, p. 2, doi. 10.2807/1560-7917.ES.2022.27.39.2200701
    By:
    • Barda, Noam;
    • Canetti, Michal;
    • Gilboa, Mayan;
    • Indenboim, Victoria;
    • Asraf, Keren;
    • Weiss-Ottolenghi, Yael;
    • Amit, Sharon;
    • Zibly⁴, Daniel;
    • Doolman, Ram;
    • Mendelson, Ella;
    • Harats, Dror;
    • Freedman, Laurence S.;
    • Kreiss, Yitshak;
    • Lustig, Yaniv;
    • Regev-Yochay, Gili
    Publication type:
    Article
    48
    49
    50